IN8BIO, INC. (INAB)
IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on developing novel therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. The company was founded by Lawrence S. Lamb and William T. Ho on February 8, 2016 and is headquartered in New York, NY.
Address
EMPIRE STATE BUILDING
NEW YORK, NY 10118
Founded
2016
Number of Employees
31
Website
http://www.in8bio.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at INAB make a trade.
Creating a free account takes less than one minute